2025-08-29 00:53:44
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
JB Chemicals and Pharmaceuticals Ltd Q2FY22 consolidated PAT at Rs. 97.75 crore
Posted On : 2021-11-13 16:20:16( TIMEZONE : IST )
JB Chemicals & Pharmaceuticals Limited has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 612.6558 crores during the period ended September 30, 2021 as compared to Rs. 618.9627 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 97.7531 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 118.8732 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 12.63 for the period ended September 30, 2021 as compared to Rs. 15.38 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 612.6558 crs | ₹618.9627 crs |  -1.02% |
| Net Profit | ₹97.7531 crs | ₹118.8732 crs | -17.77% |
| EPS | ₹12.63 | ₹15.38 | -17.88% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 612.6558 crores during the period ended September 30, 2021 as compared to Rs.451.9570 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.97.7531 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.73.8228 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.12.63 for the period ended September 30, 2021 as compared to Rs.9.55 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 612.6558 crs | ₹451.9570 crs |  35.56% |
| Net Profit | ₹97.7531 crs | ₹73.8228 crs | 32.42% |
| EPS | ₹12.63 | ₹9.55 | 32.25% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.1231.6185 crores during the 6 Months period ended September 30, 2021 as compared to Rs.996.9316 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.216.6263 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.193.2444 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.28.01 for the 6 Months period ended September 30, 2021 as compared to Rs.25.01 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹1231.6185 crs | ₹996.9316 crs | 23.54% |
| Net Profit | ₹216.6263 crs | ₹193.2444 crs | 12.10% |
| EPS | ₹28.01 | ₹25.01 | 12.00% |
Shares of JB Chemicals & Pharmaceuticals Limited was last trading in BSE at Rs. 1657.40 as compared to the previous close of Rs. 1745.90. The total number of shares traded during the day was 19395 in over 1923 trades.
The stock hit an intraday high of Rs. 1743.10 and intraday low of 1638.30. The net turnover during the day was Rs. 32486641.00.
